156 related articles for article (PubMed ID: 23239525)
1. Surrogate markers for cerebral blood flow correlate with [¹⁸F]-fallypride binding potential at dopamine D(2/3) receptors in human striatum.
Cumming P; Xiong G; la Fougère C; Rominger A; Bartenstein P; Buchholz HG; Piel M; Rösch F; Gründer G; Vernaleken I
Synapse; 2013 Apr; 67(4):199-203. PubMed ID: 23239525
[TBL] [Abstract][Full Text] [Related]
2. [18F]Fallypride PET measurement of striatal and extrastriatal dopamine D 2/3 receptor availability in recently abstinent alcoholics.
Rominger A; Cumming P; Xiong G; Koller G; Böning G; Wulff M; Zwergal A; Förster S; Reilhac A; Munk O; Soyka M; Wängler B; Bartenstein P; la Fougère C; Pogarell O
Addict Biol; 2012 Mar; 17(2):490-503. PubMed ID: 22023291
[TBL] [Abstract][Full Text] [Related]
3. Alteration of dopamine D2/D3 receptor binding in patients with juvenile myoclonic epilepsy.
Landvogt C; Buchholz HG; Bernedo V; Schreckenberger M; Werhahn KJ
Epilepsia; 2010 Sep; 51(9):1699-706. PubMed ID: 20384765
[TBL] [Abstract][Full Text] [Related]
4. D2/D3 dopamine receptor binding with [F-18]fallypride in thalamus and cortex of patients with schizophrenia.
Buchsbaum MS; Christian BT; Lehrer DS; Narayanan TK; Shi B; Mantil J; Kemether E; Oakes TR; Mukherjee J
Schizophr Res; 2006 Jul; 85(1-3):232-44. PubMed ID: 16713185
[TBL] [Abstract][Full Text] [Related]
5. Striatal and extrastriatal microPET imaging of D2/D3 dopamine receptors in rat brain with [¹⁸F]fallypride and [¹⁸F]desmethoxyfallypride.
Constantinescu CC; Coleman RA; Pan ML; Mukherjee J
Synapse; 2011 Aug; 65(8):778-87. PubMed ID: 21218455
[TBL] [Abstract][Full Text] [Related]
6. Quantification of dopamine D(2/3) receptors in rat brain using factor analysis corrected [18F]Fallypride images.
Millet P; Moulin-Sallanon M; Tournier BB; Dumas N; Charnay Y; Ibáñez V; Ginovart N
Neuroimage; 2012 Sep; 62(3):1455-68. PubMed ID: 22659483
[TBL] [Abstract][Full Text] [Related]
7. Brain imaging of 18F-fallypride in normal volunteers: blood analysis, distribution, test-retest studies, and preliminary assessment of sensitivity to aging effects on dopamine D-2/D-3 receptors.
Mukherjee J; Christian BT; Dunigan KA; Shi B; Narayanan TK; Satter M; Mantil J
Synapse; 2002 Dec; 46(3):170-88. PubMed ID: 12325044
[TBL] [Abstract][Full Text] [Related]
8. Positron emission tomography imaging of amphetamine-induced dopamine release in the human cortex: a comparative evaluation of the high affinity dopamine D2/3 radiotracers [11C]FLB 457 and [11C]fallypride.
Narendran R; Frankle WG; Mason NS; Rabiner EA; Gunn RN; Searle GE; Vora S; Litschge M; Kendro S; Cooper TB; Mathis CA; Laruelle M
Synapse; 2009 Jun; 63(6):447-61. PubMed ID: 19217025
[TBL] [Abstract][Full Text] [Related]
9. Endogenous competition against binding of [(18)F]DMFP and [(18)F]fallypride to dopamine D(2/3) receptors in brain of living mouse.
Rominger A; Wagner E; Mille E; Böning G; Esmaeilzadeh M; Wängler B; Gildehaus FJ; Nowak S; Bruche A; Tatsch K; Bartenstein P; Cumming P
Synapse; 2010 Apr; 64(4):313-22. PubMed ID: 19957365
[TBL] [Abstract][Full Text] [Related]
10. The applicability of SRTM in [(18)F]fallypride PET investigations: impact of scan durations.
Vernaleken I; Peters L; Raptis M; Lin R; Buchholz HG; Zhou Y; Winz O; Rösch F; Bartenstein P; Wong DF; Schäfer WM; Gründer G
J Cereb Blood Flow Metab; 2011 Sep; 31(9):1958-66. PubMed ID: 21587267
[TBL] [Abstract][Full Text] [Related]
11. Measuring dopamine neuromodulation in the thalamus: using [F-18]fallypride PET to study dopamine release during a spatial attention task.
Christian BT; Lehrer DS; Shi B; Narayanan TK; Strohmeyer PS; Buchsbaum MS; Mantil JC
Neuroimage; 2006 May; 31(1):139-52. PubMed ID: 16469510
[TBL] [Abstract][Full Text] [Related]
12. Cerebral morphology and dopamine D2/D3 receptor distribution in humans: a combined [18F]fallypride and voxel-based morphometry study.
Woodward ND; Zald DH; Ding Z; Riccardi P; Ansari MS; Baldwin RM; Cowan RL; Li R; Kessler RM
Neuroimage; 2009 May; 46(1):31-8. PubMed ID: 19457373
[TBL] [Abstract][Full Text] [Related]
13. Spinal cord dopamine D2/D3 receptors: in vivo and ex vivo imaging in the rat using (18)F/(11)C-fallypride.
Kaur J; Khararjian A; Coleman RA; Constantinescu CC; Pan ML; Mukherjee J
Nucl Med Biol; 2014; 41(10):841-7. PubMed ID: 25199843
[TBL] [Abstract][Full Text] [Related]
14. The simplified reference tissue model with 18F-fallypride positron emission tomography: choice of reference region.
Ishibashi K; Robertson CL; Mandelkern MA; Morgan AT; London ED
Mol Imaging; 2013; 12(8):. PubMed ID: 24447617
[TBL] [Abstract][Full Text] [Related]
15. High-affinity dopamine D2/D3 PET radioligands 18F-fallypride and 11C-FLB457: a comparison of kinetics in extrastriatal regions using a multiple-injection protocol.
Vandehey NT; Moirano JM; Converse AK; Holden JE; Mukherjee J; Murali D; Nickles RJ; Davidson RJ; Schneider ML; Christian BT
J Cereb Blood Flow Metab; 2010 May; 30(5):994-1007. PubMed ID: 20040928
[TBL] [Abstract][Full Text] [Related]
16. Small effect of dopamine release and no effect of dopamine depletion on [18F]fallypride binding in healthy humans.
Cropley VL; Innis RB; Nathan PJ; Brown AK; Sangare JL; Lerner A; Ryu YH; Sprague KE; Pike VW; Fujita M
Synapse; 2008 Jun; 62(6):399-408. PubMed ID: 18361438
[TBL] [Abstract][Full Text] [Related]
17. Parametric mapping of binding in human brain of D2 receptor ligands of different affinities.
Siessmeier T; Zhou Y; Buchholz HG; Landvogt C; Vernaleken I; Piel M; Schirrmacher R; Rösch F; Schreckenberger M; Wong DF; Cumming P; Gründer G; Bartenstein P
J Nucl Med; 2005 Jun; 46(6):964-72. PubMed ID: 15937307
[TBL] [Abstract][Full Text] [Related]
18. Dopamine D3 receptor binding of (18)F-fallypride: Evaluation using in vitro and in vivo PET imaging studies.
Mukherjee J; Constantinescu CC; Hoang AT; Jerjian T; Majji D; Pan ML
Synapse; 2015 Dec; 69(12):577-91. PubMed ID: 26422464
[TBL] [Abstract][Full Text] [Related]
19. Preliminary assessment of extrastriatal dopamine D-2 receptor binding in the rodent and nonhuman primate brains using the high affinity radioligand, 18F-fallypride.
Mukherjee J; Yang ZY; Brown T; Lew R; Wernick M; Ouyang X; Yasillo N; Chen CT; Mintzer R; Cooper M
Nucl Med Biol; 1999 Jul; 26(5):519-27. PubMed ID: 10473190
[TBL] [Abstract][Full Text] [Related]
20. Relationship of self-transcendence traits with in vivo dopamine D2/3 receptor availability and functional connectivity: An [
Kim JH; Choe YS; Cumming P; Son YD; Kim HK; Joo YH; Kim JH
Synapse; 2019 Nov; 73(11):e22121. PubMed ID: 31206840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
